Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026
The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% from 2021 to 2026. Growth in this market is driven by the increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicine.
“Consumables segment to witness the highest growth during the forecast period.”
Based on the product, the cell lysis market is segmented into cosumables and insturments. The consumables segment is projected to grow at the highest CAGR during the forecast period. purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research are the major factor supporting the growth of this segment.
“Protein purification and isolation segment to register the highest growth in the cell lysis market during the forecast period.”
Based on the application, the cell lysis market is segmented into protein purification and isolation, nucleic acid isolation and purification and other application. The protein purification and isolation segment is projected to witness the highest growth in the cell lysis market during the forecast period. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major factors supporting the growth of this segment.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the government support for vaccine production, increasing funding for cell-based research, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.
Breakdown of supply-side primary interviews, by company type, designation, and region:
This report studies the cell lysis market based on product, cell type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell lysis market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“Consumables segment to witness the highest growth during the forecast period.”
Based on the product, the cell lysis market is segmented into cosumables and insturments. The consumables segment is projected to grow at the highest CAGR during the forecast period. purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research are the major factor supporting the growth of this segment.
“Protein purification and isolation segment to register the highest growth in the cell lysis market during the forecast period.”
Based on the application, the cell lysis market is segmented into protein purification and isolation, nucleic acid isolation and purification and other application. The protein purification and isolation segment is projected to witness the highest growth in the cell lysis market during the forecast period. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major factors supporting the growth of this segment.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the government support for vaccine production, increasing funding for cell-based research, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), Director-level (34%), and Others (36%)
- By Region: North America (50%), Europe (32%), AsiaPacific (10%), and Rest of the World(8%)
- Thermo Fisher Scientific (US)
- Merck KGaA (Germany)
- Becton, Dickinson and Company (US)
- Danaher Corporation (US)
- Bio-Rad Laboratories (US)
- Cell Signaling Technology Inc. (US)
- Miltenyi Biotec (Germany)
- Roche Diagnostics (Switzerland)
- Qsonica LLC (US)
- Stemcell Technologies (US)
- Promocell (US)
- Agilent Technologies (US)
- NZYTECH (Portugal)
- Takara Bio (Japan)
- Norgen Biotek Corp. (Canada)
- Biovision (US)
This report studies the cell lysis market based on product, cell type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell lysis market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on cell lysis products offered by the top 24 players in the cell lysis market. The report analyzes the cell lysis market by product, cell type, application, end user, and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell lysis market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell lysis market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (APPLICATION-BASED)
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 CELL LYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 9 CELL LYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 10 CELL LYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 11 CELL LYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 12 CELL LYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 CELL LYSIS MARKET OVERVIEW
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE DRIVES
THE GROWTH OF THE MARKET
4.2 CELL LYSIS MARKET, BY PRODUCT
FIGURE 14 CONSUMABLES DOMINATE THE PRODUCTS MARKET
4.3 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2020
FIGURE 15 US DOMINATED THE CELL LYSIS MARKET IN 2020
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing government funding for research
FIGURE 18 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION)
5.2.1.2 High prevalence of diseases
TABLE 1 RISING INCIDENCES OF DISEASES
5.2.1.3 Growing focus on personalized medicine
FIGURE 19 RISING NUMBER OF PERSONALIZED MEDICINES, 2008–2020
5.2.2 RESTRAINTS
5.2.2.1 High cost of cell-based research and instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries
5.2.4 CHALLENGES
5.2.4.1 Survival of small players and new entrants
5.3 COVID-19 IMPACT ANALYSIS
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
FIGURE 22 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
5.7 PRICING ANALYSIS
TABLE 2 PRICES OF CELL LYSIS PRODUCTS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT FROM NEW ENTRANTS
5.8.2 INTENSITY OF COMPETITIVE RIVALRY
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 THREAT FROM SUBSTITUTES
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
5.11 REGULATORY OUTLOOK
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR HOMOGENIZERS
TABLE 3 EXPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)
TABLE 4 IMPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)
6 CELL LYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 5 CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 6 CELL LYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 REAGENTS & KITS
TABLE 8 CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 9 CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1.1 Enzymes
6.2.1.1.1 Enzymes dominated the reagents & kits market in 2020
TABLE 10 CELL LYSIS ENZYMES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Detergent solutions
6.2.1.2.1 Growing research in cell biology is a key factor driving market growth
TABLE 11 CELL LYSIS DETERGENT SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.3 Other reagents & kits
TABLE 12 OTHER CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 BEADS
6.2.2.1 Increasing investments in cell-based research form a major growth factor in this market
TABLE 13 CELL LYSIS BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 DISPOSABLES
6.2.3.1 North America to show the highest demand for cell lysis disposables
TABLE 14 CELL LYSIS DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 15 CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 16 CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 SONICATORS
6.3.1.1 Sonicators accounted for the largest share of the instruments market in 2020
TABLE 17 CELL LYSIS SONICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 HOMOGENIZERS
6.3.2.1 Investments in research and technological advancements drive market growth
TABLE 18 CELL LYSIS HOMOGENIZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 19 OTHER CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 CELL LYSIS MARKET, BY CELL TYPE
7.1 INTRODUCTION
TABLE 20 CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
7.2 MAMMALIAN CELLS
7.2.1 MAMMALIAN CELLS TO DOMINATE THE CELL LYSIS MARKET
TABLE 21 CELL LYSIS MARKET FOR MAMMALIAN CELLS, BY REGION, 2019–2026 (USD MILLION)
7.3 MICROBIAL CELLS
7.3.1 INCREASING INVESTMENT ON BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
TABLE 22 CELL LYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2019–2026 (USD MILLION)
7.4 OTHER CELLS
TABLE 23 CELL LYSIS MARKET FOR OTHER CELLS, BY REGION, 2019–2026 (USD MILLION)
8 CELL LYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 24 CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 PROTEIN PURIFICATION & ISOLATION
8.2.1 PROTEIN PURIFICATION AND ISOLATION TO DOMINATE THE CELL LYSIS MARKET DURING THE FORECAST PERIOD
TABLE 25 CELL LYSIS MARKET FOR PROTEIN PURIFICATION & ISOLATION, BY REGION, 2019–2026 (USD MILLION)
8.3 NUCLEIC ACID PURIFICATION & ISOLATION
8.3.1 INCREASING INVESTMENT IN BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
TABLE 26 CELL LYSIS MARKET FOR NUCLEIC ACID ISOLATION & PURIFICATION, BY REGION, 2019–2026 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 27 CELL LYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9 CELL LYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 RESEARCH LABORATORIES & INSTITUTES
9.2.1 RISING RESEARCH FUNDING SUPPORTS MARKET GROWTH
TABLE 29 CELL LYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
9.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3.1 RISING INVESTMENTS IN CELL-BASED RESEARCH AND THERAPY DEVELOPMENT WILL DRIVE MARKET GROWTH
TABLE 30 CELL LYSIS MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
9.4 OTHER END USERS
TABLE 31 CELL LYSIS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
10 CELL LYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 32 CELL LYSIS MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 The US dominates the market for cell lysis
TABLE 41 US: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 42 US: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 US: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 US: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 US: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 46 US: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 47 US: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 The strong and growing biopharmaceutical and biotechnology sector indicates a favorable outlook for cell lysis
TABLE 48 CANADA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 49 CANADA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 50 CANADA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 CANADA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 CANADA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 53 CANADA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 54 CANADA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 55 EUROPE: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 EUROPE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 57 EUROPE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominated the European cell lysis market in 2020
TABLE 63 GERMANY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 GERMANY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 GERMANY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 GERMANY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Government initiatives to support market growth
TABLE 70 UK: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 UK: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 UK: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 UK: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 UK: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 75 UK: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 76 UK: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing R&D investment by players to support market growth
TABLE 77 FRANCE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 FRANCE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 82 FRANCE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 83 FRANCE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Large life science research base and rising awareness support the market in Italy
TABLE 84 ITALY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 85 ITALY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 ITALY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 ITALY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 ITALY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 89 ITALY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 90 ITALY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing private and public funding to boost the market growth
TABLE 91 SPAIN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 92 SPAIN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 SPAIN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 SPAIN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 98 ROE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 ROE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ROE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 ROE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ROE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 103 ROE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 104 ROE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: CELL LYSIS MARKET SNAPSHOT
TABLE 105 ASIA PACIFIC: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 ASIA PACIFIC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 ASIA PACIFIC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to grow at the highest CAGR in the cell lysis market
TABLE 113 CHINA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 114 CHINA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 CHINA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 CHINA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 CHINA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 118 CHINA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 119 CHINA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and support for research drive market growth in Japan
TABLE 120 JAPAN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 JAPAN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 JAPAN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing government initiatives on precision medicine will boost the market growth
TABLE 127 INDIA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 INDIA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 INDIA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 INDIA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 INDIA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 133 INDIA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 ROAPAC
TABLE 134 ROAPAC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 135 ROAPAC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 ROAPAC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 ROAPAC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 ROAPAC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 139 ROAPAC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 140 ROAPAC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 ROW
TABLE 141 ROW: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 142 ROW: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 ROW: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 ROW: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 ROW: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 146 ROW: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 147 ROW: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE CELL LYSIS MARKET, JANUARY 2018– FEBRUARY 2021
FIGURE 26 MARKET EVOLUTION MATRIX: JANUARY 2018 TO JANUARY 2021
11.2 MARKET SHARE ANALYSIS
FIGURE 27 CELL LYSIS MARKET SHARE ANALYSIS, 2019
11.3 COMPANY EVALUATION MATRIX
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 28 VENDOR DIVE: CELL LYSIS MARKET
11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS)
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 29 VENDOR DIVE MATRIX FOR SMES & START-UPS: CELL LYSIS MARKET
11.5 COMPETITIVE SCENARIO
11.5.1 EXPANSIONS
TABLE 148 KEY EXPANSIONS, JANUARY 2018–FEBRUARY 2021
11.5.2 DEALS
TABLE 149 KEY DEALS, JANUARY 2018–FEBRUARY 2021
11.5.3 OTHER DEVELOPMENTS
TABLE 150 OTHER KEY DEVELOPMENTS, JANUARY 2018–FEBRUARY 2021
11.6 COMPANY PRODUCT FOOTPRINT
FIGURE 30 PRODUCT PORTFOLIO ANALYSIS: CELL LYSIS MARKET
11.7 COMPANY GEOGRAPHIC FOOTPRINT
FIGURE 31 GEOGRAPHIC ASSESSMENT: CELL LYSIS MARKET
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 KEY PLAYERS
12.1.1 THERMO FISHER SCIENTIFIC
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
12.1.2 MERCK
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.1.3 BIO-RAD LABORATORIES
FIGURE 34 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
12.1.4 BECKMAN COULTER
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.1.5 BECTON, DICKINSON AND COMPANY
FIGURE 36 BD: COMPANY SNAPSHOT (2020)
12.1.6 CELL SIGNALING TECHNOLOGY
12.1.7 MILTENYI BIOTEC
12.1.8 ROCHE DIAGNOSTICS
FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
12.1.9 QIAGEN
FIGURE 38 QIAGEN: COMPANY SNAPSHOT (2019)
12.1.10 QSONICA
12.1.11 STEMCELL TECHNOLOGIES
12.1.12 PROMOCELL
12.1.13 AGILENT TECHNOLOGIES
FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
12.1.14 PROMEGA CORPORATION
12.2 OTHER PLAYERS
12.2.1 NZYTECH
12.2.2 TAKARA BIO
FIGURE 40 TAKARA BIO: COMPANY SNAPSHOT (2020)
12.2.3 LABFREEZ INSTRUMENTS GROUP
12.2.4 G-BIOSCIENCES (GENO TECHNOLOGY)
12.2.5 COVARIS
12.2.6 CLAREMONT BIOSOLUTIONS
12.2.7 MICROFLUIDICS INTERNATIONAL CORPORATION
12.2.8 PARR INSTRUMENT COMPANY
12.2.9 BIOVISION
12.2.10 NORGEN BIOTEK CORP.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (APPLICATION-BASED)
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 CELL LYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 9 CELL LYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 10 CELL LYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 11 CELL LYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 12 CELL LYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 CELL LYSIS MARKET OVERVIEW
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE DRIVES
THE GROWTH OF THE MARKET
4.2 CELL LYSIS MARKET, BY PRODUCT
FIGURE 14 CONSUMABLES DOMINATE THE PRODUCTS MARKET
4.3 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2020
FIGURE 15 US DOMINATED THE CELL LYSIS MARKET IN 2020
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing government funding for research
FIGURE 18 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION)
5.2.1.2 High prevalence of diseases
TABLE 1 RISING INCIDENCES OF DISEASES
5.2.1.3 Growing focus on personalized medicine
FIGURE 19 RISING NUMBER OF PERSONALIZED MEDICINES, 2008–2020
5.2.2 RESTRAINTS
5.2.2.1 High cost of cell-based research and instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries
5.2.4 CHALLENGES
5.2.4.1 Survival of small players and new entrants
5.3 COVID-19 IMPACT ANALYSIS
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
FIGURE 22 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
5.7 PRICING ANALYSIS
TABLE 2 PRICES OF CELL LYSIS PRODUCTS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT FROM NEW ENTRANTS
5.8.2 INTENSITY OF COMPETITIVE RIVALRY
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 THREAT FROM SUBSTITUTES
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
5.11 REGULATORY OUTLOOK
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR HOMOGENIZERS
TABLE 3 EXPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)
TABLE 4 IMPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)
6 CELL LYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 5 CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 6 CELL LYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 REAGENTS & KITS
TABLE 8 CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 9 CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1.1 Enzymes
6.2.1.1.1 Enzymes dominated the reagents & kits market in 2020
TABLE 10 CELL LYSIS ENZYMES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Detergent solutions
6.2.1.2.1 Growing research in cell biology is a key factor driving market growth
TABLE 11 CELL LYSIS DETERGENT SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.3 Other reagents & kits
TABLE 12 OTHER CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 BEADS
6.2.2.1 Increasing investments in cell-based research form a major growth factor in this market
TABLE 13 CELL LYSIS BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 DISPOSABLES
6.2.3.1 North America to show the highest demand for cell lysis disposables
TABLE 14 CELL LYSIS DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 15 CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 16 CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 SONICATORS
6.3.1.1 Sonicators accounted for the largest share of the instruments market in 2020
TABLE 17 CELL LYSIS SONICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 HOMOGENIZERS
6.3.2.1 Investments in research and technological advancements drive market growth
TABLE 18 CELL LYSIS HOMOGENIZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 19 OTHER CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 CELL LYSIS MARKET, BY CELL TYPE
7.1 INTRODUCTION
TABLE 20 CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
7.2 MAMMALIAN CELLS
7.2.1 MAMMALIAN CELLS TO DOMINATE THE CELL LYSIS MARKET
TABLE 21 CELL LYSIS MARKET FOR MAMMALIAN CELLS, BY REGION, 2019–2026 (USD MILLION)
7.3 MICROBIAL CELLS
7.3.1 INCREASING INVESTMENT ON BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
TABLE 22 CELL LYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2019–2026 (USD MILLION)
7.4 OTHER CELLS
TABLE 23 CELL LYSIS MARKET FOR OTHER CELLS, BY REGION, 2019–2026 (USD MILLION)
8 CELL LYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 24 CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 PROTEIN PURIFICATION & ISOLATION
8.2.1 PROTEIN PURIFICATION AND ISOLATION TO DOMINATE THE CELL LYSIS MARKET DURING THE FORECAST PERIOD
TABLE 25 CELL LYSIS MARKET FOR PROTEIN PURIFICATION & ISOLATION, BY REGION, 2019–2026 (USD MILLION)
8.3 NUCLEIC ACID PURIFICATION & ISOLATION
8.3.1 INCREASING INVESTMENT IN BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
TABLE 26 CELL LYSIS MARKET FOR NUCLEIC ACID ISOLATION & PURIFICATION, BY REGION, 2019–2026 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 27 CELL LYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9 CELL LYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 RESEARCH LABORATORIES & INSTITUTES
9.2.1 RISING RESEARCH FUNDING SUPPORTS MARKET GROWTH
TABLE 29 CELL LYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
9.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3.1 RISING INVESTMENTS IN CELL-BASED RESEARCH AND THERAPY DEVELOPMENT WILL DRIVE MARKET GROWTH
TABLE 30 CELL LYSIS MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
9.4 OTHER END USERS
TABLE 31 CELL LYSIS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
10 CELL LYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 32 CELL LYSIS MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 The US dominates the market for cell lysis
TABLE 41 US: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 42 US: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 US: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 US: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 US: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 46 US: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 47 US: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 The strong and growing biopharmaceutical and biotechnology sector indicates a favorable outlook for cell lysis
TABLE 48 CANADA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 49 CANADA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 50 CANADA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 CANADA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 CANADA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 53 CANADA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 54 CANADA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 55 EUROPE: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 EUROPE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 57 EUROPE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominated the European cell lysis market in 2020
TABLE 63 GERMANY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 GERMANY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 GERMANY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 GERMANY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Government initiatives to support market growth
TABLE 70 UK: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 UK: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 UK: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 UK: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 UK: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 75 UK: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 76 UK: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing R&D investment by players to support market growth
TABLE 77 FRANCE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 FRANCE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 82 FRANCE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 83 FRANCE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Large life science research base and rising awareness support the market in Italy
TABLE 84 ITALY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 85 ITALY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 ITALY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 ITALY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 ITALY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 89 ITALY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 90 ITALY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing private and public funding to boost the market growth
TABLE 91 SPAIN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 92 SPAIN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 SPAIN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 SPAIN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 98 ROE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 ROE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ROE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 ROE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ROE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 103 ROE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 104 ROE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: CELL LYSIS MARKET SNAPSHOT
TABLE 105 ASIA PACIFIC: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 ASIA PACIFIC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 ASIA PACIFIC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to grow at the highest CAGR in the cell lysis market
TABLE 113 CHINA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 114 CHINA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 CHINA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 CHINA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 CHINA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 118 CHINA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 119 CHINA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and support for research drive market growth in Japan
TABLE 120 JAPAN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 JAPAN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 JAPAN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing government initiatives on precision medicine will boost the market growth
TABLE 127 INDIA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 INDIA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 INDIA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 INDIA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 INDIA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 133 INDIA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 ROAPAC
TABLE 134 ROAPAC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 135 ROAPAC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 ROAPAC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 ROAPAC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 ROAPAC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 139 ROAPAC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 140 ROAPAC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 ROW
TABLE 141 ROW: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 142 ROW: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 ROW: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 ROW: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 ROW: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 146 ROW: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 147 ROW: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE CELL LYSIS MARKET, JANUARY 2018– FEBRUARY 2021
FIGURE 26 MARKET EVOLUTION MATRIX: JANUARY 2018 TO JANUARY 2021
11.2 MARKET SHARE ANALYSIS
FIGURE 27 CELL LYSIS MARKET SHARE ANALYSIS, 2019
11.3 COMPANY EVALUATION MATRIX
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 28 VENDOR DIVE: CELL LYSIS MARKET
11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS)
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 29 VENDOR DIVE MATRIX FOR SMES & START-UPS: CELL LYSIS MARKET
11.5 COMPETITIVE SCENARIO
11.5.1 EXPANSIONS
TABLE 148 KEY EXPANSIONS, JANUARY 2018–FEBRUARY 2021
11.5.2 DEALS
TABLE 149 KEY DEALS, JANUARY 2018–FEBRUARY 2021
11.5.3 OTHER DEVELOPMENTS
TABLE 150 OTHER KEY DEVELOPMENTS, JANUARY 2018–FEBRUARY 2021
11.6 COMPANY PRODUCT FOOTPRINT
FIGURE 30 PRODUCT PORTFOLIO ANALYSIS: CELL LYSIS MARKET
11.7 COMPANY GEOGRAPHIC FOOTPRINT
FIGURE 31 GEOGRAPHIC ASSESSMENT: CELL LYSIS MARKET
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 KEY PLAYERS
12.1.1 THERMO FISHER SCIENTIFIC
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
12.1.2 MERCK
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.1.3 BIO-RAD LABORATORIES
FIGURE 34 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
12.1.4 BECKMAN COULTER
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.1.5 BECTON, DICKINSON AND COMPANY
FIGURE 36 BD: COMPANY SNAPSHOT (2020)
12.1.6 CELL SIGNALING TECHNOLOGY
12.1.7 MILTENYI BIOTEC
12.1.8 ROCHE DIAGNOSTICS
FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
12.1.9 QIAGEN
FIGURE 38 QIAGEN: COMPANY SNAPSHOT (2019)
12.1.10 QSONICA
12.1.11 STEMCELL TECHNOLOGIES
12.1.12 PROMOCELL
12.1.13 AGILENT TECHNOLOGIES
FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
12.1.14 PROMEGA CORPORATION
12.2 OTHER PLAYERS
12.2.1 NZYTECH
12.2.2 TAKARA BIO
FIGURE 40 TAKARA BIO: COMPANY SNAPSHOT (2020)
12.2.3 LABFREEZ INSTRUMENTS GROUP
12.2.4 G-BIOSCIENCES (GENO TECHNOLOGY)
12.2.5 COVARIS
12.2.6 CLAREMONT BIOSOLUTIONS
12.2.7 MICROFLUIDICS INTERNATIONAL CORPORATION
12.2.8 PARR INSTRUMENT COMPANY
12.2.9 BIOVISION
12.2.10 NORGEN BIOTEK CORP.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
